Biologics Market Biologics Market Segmentation by Product - Monoclonal Antibodies, Vaccines, Cell Therapy, Recombinant Hormones/Proteins, and Gene Therapy; Applications - Infectious Diseases, Oncology, Immunology, and Autoimmune Diseases - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016-2024
Table of Content Sr. No. Chapter 1 Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7 Chapter 8 Chapter 9 Chapter 10 Chapter 11 Chapter 12 Chapter 13 Chapter 14 Content Preface Assumptions and Research Methodology Executive Summary Market Overview Market Dynamics Global Biologics Market Analysis and Forecasts, By Product Global Biologics Market Analysis and Forecasts, By Application Global Biologics Market Analysis and Forecasts, By Region North America Biologics Market Analysis and Forecast Europe Biologics Market Analysis and Forecast Asia Pacific Biologics Market Analysis and Forecast Latin America Biologics Market Analysis and Forecast MEA Biologics Market Analysis and Forecast Competition Landscape
Biologics Market - Snapshot The biologics market is expected to grow at an impressive pace during the forecast period. The gains will be driven by substantial investments in R&D activities in the biotechnology & pharmaceutical sector and the soaring demand for novel therapies for various rare diseases. The introduction of recombinant DNA technology has expanded the potential of the biologics market. The emergence of promising drug candidates has made several global and regional pharmaceutical players venture into the biologics market.
Reports Highlights The global biologics market is forecast to expand at a CAGR of 10.9% over the period 2016 2024. Maintaining a steady pace of growth, the market is anticipated to attain a valuation of US$479, 752 mn by the end of the forecast period. Pharmaceutical firms patenting biologics products have been anticipated to make healthy gains in the coming years. Request For Sample
Continue.. Several players are making large investments in expanding their biologics facilities across major geographic regions to gain a stronghold in this market. Leading players are launching novel therapies approved by the FDA to gain a competitive edge over others. Few of the leading players in this market are AbbVie Inc., AstraZeneca, Amgen Inc., F. Hoffmann-La Roche Ltd, Bayer AG, Sanofi, Eli Lilly and Company. Request For Brochure
Contact To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com Thank You